Sanofi Has One Hemophilia Winner On It Hands – But Fitusiran’s Fate Remains Unclear

Efanesoctocog Alfa Filed Last Month

 
• By Andrew McConaghie
  
Sanofi_Berlin
Sanofi could be a major player in hemophilia within a few years - but will face competition from Roche's Hemlibra and gene therapies. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Blood and Clotting

More from Therapeutic Category